Reata Pharmaceuticals Inc (RETA) Gross Profit Margin starting from the second quarter 2023 to second quarter 2022, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket
 


Reata Pharmaceuticals Inc   (NASDAQ: RETA)


Reata Pharmaceuticals Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics



RETA Gross Profit Margin (Jun 30 2023)
Q2
(Mar 31 2023)
Q1
(Dec 31 2022)
Q4
(Sep 30 2022)
Q3
(Jun 30 2022)
Q2
Y / Y Revenue Change 2885.04 %
Seq. Revenue Change 11564.62 %
Revenue In Millions $22.75
Gross Profit Margin 0 %
Gross Profit Margin Total Ranking # 776
Gross Profit In Millions $0.00
Y / Y Gross Profit Change -
Seq. Gross Profit Change -


Commenting Second Quarter 2023 Gross Profit Margin



Observing second quarter 2023 results within Major Pharmaceutical Preparations industry 128 other companies have achieved higher Gross Profit Margin. While overall Gross Profit Margin ranking remained unchanged compared to the previous quarter at no. .
Learn about Gross Margin
RETA's Gross Profit Margin second quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 129
Healthcare Sector # 225
Overall # 776

Gross Profit Margin Statistics
High Average Low
100 % 100 % 100 %
(Jun 30 2023)  




Other Gross Profit Margin Profitability Ratios
RETA's Cumulative Gross Profit Margin
Major Pharmaceutical Preparations Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
RETA's Gross Profit Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for RETA's Competitors
Gross Profit Margin Profit Margin for Reata Pharmaceuticals Inc 's Suppliers
Gross Profit Margin Profit Margin for RETA's Customers

You may also want to know
RETA's Annual Growth Rates RETA's Profitability Ratios RETA's Asset Turnover Ratio RETA's Dividend Growth
RETA's Roe RETA's Valuation Ratios RETA's Financial Strength Ratios RETA's Gross Profit Growth
RETA's Roa RETA's Inventory Turnover Ratio RETA's Growth Rates RETA's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Jun 30 2023, within Major Pharmaceutical Preparations Industry Gross Profit MarginJun 30 2023 MRQ Gross ProfitJun 30 2023 MRQ Revenue




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.